[144] Freightos Ltd SEC Filing

Rhea-AI Filing Summary

Freightos Ltd (CRGO) filed a Form 144 reporting a proposed sale of 18,606 ordinary shares through Oppenheimer & Co. on Nasdaq with an approximate sale date of 09/16/2025. The filing lists an aggregate market value of $56,190.12 against total shares outstanding of 49,726,906. The securities were acquired as Restricted Stock Units from the issuer on 06/09/2025, totaling 27,910 units, with payment recorded on the same date.

The notice contains the standard representation that the seller does not possess undisclosed material information and includes the usual signature and legal warning language. No other sales in the past three months were reported and no donor/gift information or relationship to issuer is specified in the filing.

Insights

Securities Analyst

TL;DR: A small insider sale filing; value is immaterial relative to outstanding shares and signals standard post-vesting disposition.

The Form 144 discloses a proposed sale of 18,606 shares valued at $56,190.12, representing a very small fraction of the 49.7M shares outstanding. The shares were acquired as RSUs on 06/09/2025 and the sale is to occur via a broker on 09/16/2025. From a market-impact perspective this transaction appears routine and unlikely to move the stock materially given the dollar size and proportion of float. The filing fulfills Rule 144 disclosure requirements.

Corporate Governance Expert

TL;DR: Filing shows compliance with disclosure rules; no evidence in this notice of undisclosed material information.

The notice includes the required attestation that the seller is not aware of material nonpublic information and shows acquisition via RSUs, which suggests a typical executive/employee post-vesting sale rather than a sale tied to extraordinary events. The absence of other recent sales reported for the past three months and the limited size reduce concerns about governance-related signaling. The filing lacks details on the seller's relationship to the issuer, which is not uncommon but limits deeper governance interpretation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	18606	56190.12	49726906	09/16/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	06/09/2025	Restricted Stock Units	Issuer			27910	06/09/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Freightos (CRGO) report in the Form 144?

The filing reports a proposed sale of 18,606 ordinary shares via Oppenheimer & Co., with an aggregate market value of $56,190.12 and an approximate sale date of 09/16/2025.

How were the shares acquired that are to be sold?

The securities were acquired as Restricted Stock Units (RSUs) from the issuer on 06/09/2025, amounting to 27,910 units.

Does the Form 144 report other sales in the past three months for this person?

No. The filing states Nothing to Report for securities sold during the past three months.

What attestation does the filer make in the notice?

The person signing the notice represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.

Through which broker will the sale be executed and on which exchange?

The sale is listed to be executed through Oppenheimer & Co. Inc. on Nasdaq.